BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 9727550)

  • 1. Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor-alpha and angiotensin II.
    Nakamura K; Fushimi K; Kouchi H; Mihara K; Miyazaki M; Ohe T; Namba M
    Circulation; 1998 Aug; 98(8):794-9. PubMed ID: 9727550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effect of antisense oligodeoxynucleotide to p44/p42 MAPK on angiotensin II-induced hypertrophic response in cultured neonatal rat cardiac myocyte.
    Zhang SQ; Ding B; Guo ZG; Li YX
    Acta Pharmacol Sin; 2004 Jan; 25(1):41-6. PubMed ID: 14704121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress mediates tumor necrosis factor-alpha-induced mitochondrial DNA damage and dysfunction in cardiac myocytes.
    Suematsu N; Tsutsui H; Wen J; Kang D; Ikeuchi M; Ide T; Hayashidani S; Shiomi T; Kubota T; Hamasaki N; Takeshita A
    Circulation; 2003 Mar; 107(10):1418-23. PubMed ID: 12642364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tetramethylpyrazine inhibits angiotensin II-induced cardiomyocyte hypertrophy and tumor necrosis factor-α secretion through an NF-κB-dependent mechanism.
    Yu L; She T; Li M; Shi C; Han L; Cheng M
    Int J Mol Med; 2013 Sep; 32(3):717-22. PubMed ID: 23842595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heme oxygenase-1 inhibits angiotensin II-induced cardiac hypertrophy in vitro and in vivo.
    Hu CM; Chen YH; Chiang MT; Chau LY
    Circulation; 2004 Jul; 110(3):309-16. PubMed ID: 15226216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of all-trans retinoic acid on angiotensin II-induced myocyte hypertrophy.
    Wang HJ; Zhu YC; Yao T
    J Appl Physiol (1985); 2002 May; 92(5):2162-8. PubMed ID: 11960970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of resveratrol on angiotensin II-induced cardiomyocyte hypertrophy.
    Cheng TH; Liu JC; Lin H; Shih NL; Chen YL; Huang MT; Chan P; Cheng CF; Chen JJ
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Feb; 369(2):239-44. PubMed ID: 14663554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isorhapontigenin, a new resveratrol analog, attenuates cardiac hypertrophy via blocking signaling transduction pathways.
    Li HL; Wang AB; Huang Y; Liu DP; Wei C; Williams GM; Zhang CN; Liu G; Liu YQ; Hao DL; Hui RT; Lin M; Liang CC
    Free Radic Biol Med; 2005 Jan; 38(2):243-57. PubMed ID: 15607907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inhibitory effect of tea polyphenols and EGCG on cultured hypertrophic myocyte induced by Ang II].
    Cui W; Mao W; Du H; Li N
    Wei Sheng Yan Jiu; 2008 May; 37(3):356-8. PubMed ID: 18646540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine D2 receptor stimulation inhibits angiotensin II-induced hypertrophy in cultured neonatal rat ventricular myocytes.
    Li H; Shi S; Sun YH; Zhao YJ; Li QF; Li HZ; Wang R; Xu CQ
    Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):312-8. PubMed ID: 18986329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polydatin prevents angiotensin II-induced cardiac hypertrophy and myocardial superoxide generation.
    Zhang Q; Tan Y; Zhang N; Yao F
    Exp Biol Med (Maywood); 2015 Oct; 240(10):1352-61. PubMed ID: 25488910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific role of the extracellular signal-regulated kinase pathway in angiotensin II-induced cardiac hypertrophy in vitro.
    Aoki H; Richmond M; Izumo S; Sadoshima J
    Biochem J; 2000 Apr; 347 Pt 1(Pt 1):275-84. PubMed ID: 10727428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1.
    Morikawa-Futamatsu K; Adachi S; Maejima Y; Tamamori-Adachi M; Suzuki J; Kitajima S; Ito H; Isobe M
    Life Sci; 2006 Aug; 79(14):1380-90. PubMed ID: 16712874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NADPH oxidase-derived superoxide anion mediates angiotensin II-induced cardiac hypertrophy.
    Nakagami H; Takemoto M; Liao JK
    J Mol Cell Cardiol; 2003 Jul; 35(7):851-9. PubMed ID: 12818576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II increases secreted frizzled-related protein 5 (sFRP5) expression through AT1 receptor/Rho/ROCK1/JNK signaling in cardiomyocytes.
    Jin X; Guo B; Yan J; Yang R; Chang L; Wang Y; Miao C; Liu S; Zhang H; Li Y
    Mol Cell Biochem; 2015 Oct; 408(1-2):215-22. PubMed ID: 26126628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactive oxygen species modulate angiotensin II-induced beta-myosin heavy chain gene expression via Ras/Raf/extracellular signal-regulated kinase pathway in neonatal rat cardiomyocytes.
    Shih NL; Cheng TH; Loh SH; Cheng PY; Wang DL; Chen YS; Liu SH; Liew CC; Chen JJ
    Biochem Biophys Res Commun; 2001 Apr; 283(1):143-8. PubMed ID: 11322781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of an AT1 receptor antagonist (CV-11974) on angiotensin II-induced cardiomyocyte hypertrophy in vitro.
    Hirata Y; Kanno K; Eguchi S; Kano H
    Blood Press Suppl; 1994; 5():84-8. PubMed ID: 7889209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of pioglitazone on the expression of inflammatory cytokines in attenuating rat cardiomyocyte hypertrophy.
    Ye P; Yang W; Wu SM; Sheng L
    Methods Find Exp Clin Pharmacol; 2006 Dec; 28(10):691-6. PubMed ID: 17235413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclophilin A promotes cardiac hypertrophy in apolipoprotein E-deficient mice.
    Satoh K; Nigro P; Zeidan A; Soe NN; Jaffré F; Oikawa M; O'Dell MR; Cui Z; Menon P; Lu Y; Mohan A; Yan C; Blaxall BC; Berk BC
    Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1116-23. PubMed ID: 21330604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cultured neonatal rat cardiac myocytes and fibroblasts do not synthesize renin or angiotensinogen: evidence for stretch-induced cardiomyocyte hypertrophy independent of angiotensin II.
    van Kesteren CA; Saris JJ; Dekkers DH; Lamers JM; Saxena PR; Schalekamp MA; Danser AH
    Cardiovasc Res; 1999 Jul; 43(1):148-56. PubMed ID: 10536699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.